Azenta Inc (AZTA)
53.20
+1.02
(+1.95%)
USD |
NASDAQ |
Apr 29, 16:00
53.20
0.00 (0.00%)
After-Hours: 19:05
Azenta Enterprise Value: 1.926B for April 26, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 26, 2024 | 1.926B |
| April 25, 2024 | 1.888B |
| April 24, 2024 | 1.921B |
| April 23, 2024 | 1.946B |
| April 22, 2024 | 1.855B |
| April 19, 2024 | 1.840B |
| April 18, 2024 | 1.831B |
| April 17, 2024 | 1.869B |
| April 16, 2024 | 1.926B |
| April 15, 2024 | 2.002B |
| April 12, 2024 | 2.069B |
| April 11, 2024 | 2.160B |
| April 10, 2024 | 2.157B |
| April 09, 2024 | 2.240B |
| April 08, 2024 | 2.179B |
| April 05, 2024 | 2.221B |
| April 04, 2024 | 2.260B |
| April 03, 2024 | 2.307B |
| April 02, 2024 | 2.296B |
| April 01, 2024 | 2.308B |
| March 28, 2024 | 2.377B |
| March 27, 2024 | 2.330B |
| March 26, 2024 | 2.272B |
| March 25, 2024 | 2.240B |
| March 22, 2024 | 2.323B |
| Date | Value |
|---|---|
| March 21, 2024 | 2.319B |
| March 20, 2024 | 2.289B |
| March 19, 2024 | 2.289B |
| March 18, 2024 | 2.260B |
| March 15, 2024 | 2.334B |
| March 14, 2024 | 2.321B |
| March 13, 2024 | 2.591B |
| March 12, 2024 | 2.623B |
| March 11, 2024 | 2.648B |
| March 08, 2024 | 2.662B |
| March 07, 2024 | 2.760B |
| March 06, 2024 | 2.636B |
| March 05, 2024 | 2.648B |
| March 04, 2024 | 2.702B |
| March 01, 2024 | 2.769B |
| February 29, 2024 | 2.649B |
| February 28, 2024 | 2.652B |
| February 27, 2024 | 2.647B |
| February 26, 2024 | 2.604B |
| February 23, 2024 | 2.550B |
| February 22, 2024 | 2.550B |
| February 21, 2024 | 2.547B |
| February 20, 2024 | 2.591B |
| February 16, 2024 | 2.594B |
| February 15, 2024 | 2.622B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.073B
Minimum
Sep 27 2022
9.052B
Maximum
Nov 08 2021
3.625B
Average
2.881B
Median
May 02 2022
Enterprise Value Benchmarks
| Bruker Corp | 11.98B |
| Harvard Bioscience Inc | 189.39M |
| Bionano Genomics Inc | 16.05M |
| Akoya Biosciences Inc | 178.86M |
| Singular Genomics Systems Inc | -135.16M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -15.72M |
| Revenue (Quarterly) | 154.32M |
| Total Expenses (Quarterly) | 179.87M |
| EPS Diluted (Quarterly) | -0.28 |
| Gross Profit Margin (Quarterly) | 39.86% |
| Profit Margin (Quarterly) | -10.19% |
| Earnings Yield | -0.58% |
| Normalized Earnings Yield | -0.8551 |